Results 131 to 140 of about 25,152,973 (316)

2014 Alzheimer's Disease Facts and Figures

open access: yes, 2014
2014 Alzheimer’s Disease Facts and Figures is a statistical resource for U.S. data related to Alzheimer’sdisease, the most common type of dementia, as well as other dementias.
Alzheimer's Association (US)
core   +1 more source

Individuals With Multijoint Osteoarthritis Demonstrate Larger Longitudinal Declines in Frailty: Data From the Canadian Longitudinal Study on Aging

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to test the hypothesis that multijoint osteoarthritis would modify the relation between time and frailty progression, in which more affected joints would lead to larger declines over six years compared to those without osteoarthritis using data from the Canadian Longitudinal Study on Aging.
Carson Halliwell   +2 more
wiley   +1 more source

Review: Exploration of Alzheimer\'s Disease

open access: yesJournal of Rehabilitation, 2006
In the 8th edition (1910) of "Psychiatric: Ein Lehrbuch fur Studirende und Arzte", Kraepelin stated that a "particular group of cases with extremely serious cell alterations" were discussed by Alzheimer. Those changes were: "Excessively numerous plaques,
Farbod Fadaei
doaj  

Additional file 1: of Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimerâ s disease

open access: yes, 2016
BexProtocol-Ver#2-8-1-12. (DOC 299 kb)
Cummings, Jeffrey   +9 more
openaire   +1 more source

A Scoping Review and Meta‐Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease

open access: yesArthritis Care &Research, Accepted Article.
Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary   +21 more
wiley   +1 more source

Pathogenesis of Alzheimer′s disease

open access: yesClinical Interventions in Aging, 2007
Russell H SwerdlowDepartment of Neurology, University of Virginia School of Medicine, Charlottesville, VA, USAAbstract: Alzheimer’s disease (AD) is incredibly common. Increasing longevity ensures its prevalence will rise even further.
Russell H Swerdlow
doaj  

Additional file 2: of Psychosocial interventions for Alzheimerâ s disease cognitive symptoms: a Bayesian network meta-analysis

open access: yes, 2018
Risk of Bias Graph. (DOCX 31 kb)
Duan, Yuting   +8 more
openaire   +1 more source

Engineered Nanotopography to Modulate Growth and Signaling of Neuronal Networks

open access: yesAdvanced Functional Materials, EarlyView.
This study examines the interaction between neurons and nanoscale topographies on engineered substrates. Neurons cultured on nanowires, nanopillars and nanoneedles exhibit enhanced neurite outgrowth, form more organized neuronal circuits, and display improved synaptic connectivity, compared to flat substrates.
Hao Nguyen Tran   +8 more
wiley   +1 more source

Using functional Magnetic Resonance Imaging to differentiate between healthy aging subjects, Mild Cognitive Impairment, and Alzheimer′s patients

open access: yesJournal of Research in Medical Sciences, 2010
Background: Alzheimer′s disease is the most common form of dementia which is still difficult to be differentiated from other types of brain disorders. Moreover, Mild Cognitive Impairment refers to the presence of cognitive impairments that is not severe ...
Mohammad Ali Oghabian   +4 more
doaj  

Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential

open access: yesAdvanced Healthcare Materials, EarlyView.
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy